Dr Reddys Laboratories Share Price Today - Live Blog for July 10, 2025

Dr Reddys Laboratories Ltd witnessed a -0.18% decrease in its share price, and it is currently trading at ₹1,260.50. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.7400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.08% drop, and it's now trading at ₹1,262.50 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.08%, reaching a current market price of ₹1,266.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

After a -0.08% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,266.00. The stock has a PE ratio of 18.7400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

After a -0.05% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,266.95. The stock has a PE ratio of 18.7400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.19% drop, and it's now trading at ₹1,266.50 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd experienced a -0.02% dip in its share price and is currently trading at ₹1,267.80. The stock has a PE ratio of 18.7400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price has declined by -0.11%, and it's currently trading at ₹1,267.70. The stock maintains a PE of 18.7400, while the industry PE is 35.0068, prompting discussions about its valuation.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.10% increase. Presently, it is actively trading at ₹1,268.80.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.11% in its share price, and it currently trades at ₹1,267.55 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price rallied by 0.07%, reaching the current market price of ₹1,268.95. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.02%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,267.05, and market participants are assessing the implications. The stock has a PE ratio of 18.7400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.08% uptick in its share price. As a result, it's now actively trading at ₹1,266.00 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.00%, and as of now, it's trading at ₹1,264.80 per share. This upward trajectory is attracting keen interest from investors.

With a remarkable 0.17% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,265.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.7400, while the industry's PE ratio is 35.0068.

After a notable 0.43% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,262.95. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.14%. At this moment, it's actively trading at ₹1,258.05, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd shares experienced a -0.02% reduction, with the current market price at ₹1,256.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.27% gain, with the share price now at ₹1,256.95. Notably, the stock's PE ratio stands at 18.7400, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd witnessed a -0.17% decrease in its share price, and it is currently trading at ₹1,255.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.7400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.17% drop, and it's now trading at ₹1,255.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Following a noteworthy 0.01% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,257.10. When it comes to valuation, this stock has a PE ratio of 18.7400, with the industry PE ratio at 35.0068.

The share price of Dr Reddys Laboratories Ltd plunged by -0.09%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,255.40, but investors are assessing whether this is a temporary dip or a long-term trend.

With a -0.09% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,255.40. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.7400, while the industry PE is 35.0068.

Dr Reddys Laboratories Ltd's share price has fallen by -0.24%, a situation worth noting. At present, the stock is trading at ₹1,256.95. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.7400, while the industry PE ratio is 35.0068.

With a -0.75% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,260.00. Investors should examine the factors driving this decline. The stock's PE ratio is 18.7400, whereas the industry PE ratio stands at 35.0068.